| Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis | |
| Zhou, Zhan1,2; Zhang, Jing1; Zhang, Yan1; Ma, Guanghui1; Su, Zhiguo1 | |
| 2016 | |
| 发表期刊 | BIOCONJUGATE CHEMISTRY
 |
| ISSN | 1043-1802 |
| 卷号 | 27期号:1页码:238-246 |
| 摘要 | Conventional preparation strategies for antibody-drug conjugates (ADCs) result in heterogeneous products with various molecular sizes and species. In this study, we developed a homogeneous preparation strategy by site-specific conjugation of the anticancer drug with an antibody fragment. The model drug doxorubicin (DOX) was coupled to the Fab' fragment of anti-CD20 IgG at its permissive sites through a heterotelechelic PEG linker, generating an antibody fragment-drug conjugate (AFDC). Anti-CD20 IgG was digested and reduced specifically with beta-mercaptoethylamine to generate the Fab' fragment with two free mercapto groups in its hinge region. Meanwhile, DOX was conjugated with alpha-succinimidylsuccinate omega-maleimide polyethylene glycol (NHS-PEG-MAL) to form MAL-PEG-DOX, which was subsequently linked to the free mercapto containing Fab' fragment to form a Fab'-PEG-DOX conjugate. The dual site-specific bioconjugation was achieved through the combination of highly selective reduction of IgG and introduction of heterotelechelic PEG linker. The resulting AFDC provides an utterly homogeneous product, with a definite ratio of one fragment to two drugs. Laser confocal microscopy and cell ELISA revealed that the AFDC could accumulate in the antigen-positive Daudi tumor cell. In addition, the Fab'-PEG-DOX retained appreciable targeting ability and improved antitumor activity, demonstrating an excellent therapeutic effect on the lymphoma mice model for better cure rate and significantly reduced side effects. |
| 文章类型 | Article |
| WOS标题词 | Science & Technology ; Life Sciences & Biomedicine ; Physical Sciences |
| DOI | 10.1021/acs.bioconjchem.5b00626 |
| 收录类别 | SCI |
| 语种 | 英语 |
| 关键词[WOS] | MONOCLONAL-ANTIBODY ; THERAPEUTIC INDEX ; CANCER-THERAPY ; DOXORUBICIN ; EXPRESSION ; ANTI-CD20 ; GROWTH ; POTENT ; CELLS |
| WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry |
| WOS类目 | Biochemical Research Methods ; Biochemistry & Molecular Biology ; Chemistry, Multidisciplinary ; Chemistry, Organic |
| 项目资助者 | National Natural Science Foundation of China(21106163 ; Science and Technology Service Network Initiative(KFJ-EW-STS-027) ; National High Technology Research and Development Program of China (863 Program)(2012AA021202 ; National Key Basic Research Program of China (973 Program)(2013CB733600) ; National Key Foundation for Exploring Scientific Instrument of China(2013YQ14040508) ; 21306207 ; 2012AA02A406 ; 21336010) ; 2014AA021006) |
| WOS记录号 | WOS:000368651600026 |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.ipe.ac.cn/handle/122111/20598 |
| 专题 | 生化工程国家重点实验室 |
| 作者单位 | 1.Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, 1 Beierjie St, Beijing 100190, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhou, Zhan,Zhang, Jing,Zhang, Yan,et al. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis[J]. BIOCONJUGATE CHEMISTRY,2016,27(1):238-246. |
| APA | Zhou, Zhan,Zhang, Jing,Zhang, Yan,Ma, Guanghui,&Su, Zhiguo.(2016).Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.BIOCONJUGATE CHEMISTRY,27(1),238-246. |
| MLA | Zhou, Zhan,et al."Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis".BIOCONJUGATE CHEMISTRY 27.1(2016):238-246. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| Specific Conjugation（3940KB） | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 浏览 请求全文 | |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论